41 results on '"Rahnama'i, Mohammad Sajjad"'
Search Results
2. Lower Urinary Tract Symptoms (LUTS) and COVID-19
3. Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
4. Lower urinary tract signs and symptoms in patients with COVID-19
5. Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?
6. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment?
7. The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function
8. Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
9. Microbiome in Lower Urinary Tract Symptoms (LUTSs): Mapping the State of the Art with Bibliometric Analysis
10. Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
11. Long-term follow-up of intravesical abobotulinumtoxinA (Dysport) injections in women with idiopathic detrusor overactivity
12. Botulinum Toxin Therapy for Bladder Pain Syndrome/Interstitial Cystitis.
13. Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
14. Diagnosis and treatment of nocturnal enuresis throughout the ages
15. MP32-17 EFFECTIVITY OF A NOVEL IMPLANTABLE DEVICE (STIMROUTER) FOR THE TREATMENT OF OVERACTIVE BLADDER SYNDROME: 30 MONTHS RESULTS OF A MULTI-CENTRE STUDY
16. Storage symptoms after surgical treatment of stress urinary incontinence in women: a clinical review
17. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta‐analysis
18. Prostaglandin Receptor EP1 and EP2 Site in Guinea Pig Bladder Urothelium and Lamina Propria
19. The Scientific Value of Abstracts on Prostate Cancer Presented at the European Association of Urology Congresses
20. Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx ?
21. Lower Urinary Tract Signs and Symptoms in COVID-19 infected Patients
22. Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai – India
23. Neuromodulation for functional bladder disorders in patients with multiple sclerosis
24. How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI‐RS 2018
25. Are there different patterns of detrusor overactivity which are clinically relevant? ICI‐RS 2018
26. Botulinum toxin A for refractory OAB and idiopathic urinary retention: Can phenotyping improve outcome for patients: ICI‐RS 2019?
27. How can we improve the diagnosis and management of bladder pain syndrome? Part 1: ICI‐RS 2018
28. Neuromodulation for functional bladder disorders in patients with multiple sclerosis.
29. Botulinum toxin A for refractory OAB and idiopathic urinary retention: Can phenotyping improve outcome for patients: ICI‐RS 2019?
30. The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function
31. Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?
32. Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015)
33. Pathophysiological mechanisms in detrusor underactivity: Novel experimental findings.
34. Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders
35. Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction
36. The Relationship Between Prostaglandin E Receptor 1 and Cyclooxygenase I Expression in Guinea Pig Bladder Interstitial Cells: Proposition of a Signal Propagation System
37. Urinary Microbiome and its Correlation with Disorders of the Genitourinary System.
38. A systematic and comprehensive review of the role of microbiota in urinary chronic pelvic pain syndrome.
39. Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
40. Urinary Microbiome and its Correlation with Disorders of the Genitourinary System.
41. Wired bladder in a cordless era.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.